Nestle has launched a review of its underperforming vitamins business that could lead to the divestment of some brands, it said on Thursday, after reporting its first-half sales volumes grew more ...

Leadership changes, EBITDA guidance revisions, and Medicaid policy headwinds highlight a critical Q2 2025 for CYH.